Dr. Paciucci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Sw 16th St., Suite 100
Renton, WA 98057Phone+1 425-204-7480Fax+1 425-204-7481
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1980 - 1983
- Sapienza University of RomeClass of 1973
- Liceo Scientifico �Augusto Righi�Bachelor, 1962 - 1967
Certifications & Licensure
- NY State Medical License 1983 - 2024
- PA State Medical License 2016 - 2021
- ND State Medical License 2016 - 2018
- WA State Medical License 2013 - 2018
- ID State Medical License 2013 - 2017
- WI State Medical License 2013 - 2017
Publications & Presentations
PubMed
- 9 citationsNeo-adjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancer.Paolo Alberto Paciucci, George Raptis, Ira J. Bleiweiss, Christina Weltz, Deborah Lehrer
Anti-Cancer Drugs. 2002-09-01 - 157 citationsPostremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-d...Richard Stone, Deborah T. Berg, Stephen L. George, Richard K. Dodge, PA Paciucci
Blood. 2001-08-01 - 3 citationsInterleukin-2 plus chemotherapy for patients with metastatic melanoma.Paolo Alberto Paciucci, J. S. Ryder, J P Mandell, J C Morris, J F Holland
Melanoma Research. 2000-06-01
Journal Articles
- Neoadjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancerP.A. Paciucci, Raptis, G., Bleiweiss, I., Weltz, C., Lehrer, D., Gurry, R., Anti-cancer Drugs, 1/1/2002
- Post Remission Therapy in Older Patients with de novo Acute Myeloid Leukemia (AML): A Randomized Trial of Mitoxantrone/Intermediate Dose Cytarabine (CALGB Study 8923)Stone, R., Berg, D.T., George, S.l., Dodge, R.K. Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B., Bloomfield, C., Schiffer, C.A., Blood, 1/1/2001
- Interleukin-2 plus chemotherapy for patients with metastatic melanomaPaciucci, P.A., Mauri, S., Ryder, S.J., Mandeli, J., Morris, J.C., Holland, J.F., Melanoma Research, 1/1/2000
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Dose-dense Neoadjuvant Taxotere for stage III breast Cancer.Paciucci, P.A., ASCO, 1/1/2002
- A Phase I-II of Topotecan and Cladribinr with Granulocyte Stimulating Factor (G-CFS) Support in Relapsed, Refractory and Poor Prognosis Acute Myeloid Leukemia.L.R. Silverman, R. Jakubowski, P.A. Paciucci, R. Brenner, E. Scigliano, J. Gabrilove, Am Soc Hemat, 1/1/2001
- Meningiona cell lines derived from human tumor explants: establishment, characterization and proliferation analysis.Paino, J.E., Hague, K., Ryder, J.S., Paciucci, P.A., Sen, C., Proc Am Assoc Neurological Surgeons, 1/1/1998
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: